Long-term administration of theophylline and glucose recovery after hypoglycaemia in patients with type 1 diabetes mellitus

Diabetic Medicine

Volumn 15, Issue 7, 1998, Pages 608-614

  Hvidberg, A ^a   Rosenfalck, A ^a   Christensen, N J ^b   Hilsted, J ^a,c  

^a HVIDOVRE HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Glucose metabolism; Hypoglycaemia; Theophylline

Indexed keywords

AMINOPHYLLINE; CYCLIC AMP; NEUTRAL INSULIN; PLACEBO;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCOGENOLYSIS; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ORAL DRUG ADMINISTRATION; SECOND MESSENGER;

EID: 0031857225     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9136(199807)15:7<608::aid-dia618>3.0.co;2-%23     Document Type: Article

References (25)

1. Rizza RA, Haymond M, Gerich JE. Theophylline potentiates glucagon induced hepatic glucose production in man but does not prevent hepatic downregulation to glucagon. Metabolism 1982; 31: 205-208.
2. Smith SR, Kendall MJ. Potentiation of the adverse effects of intravenous terbutaline by oral theophylline. Br J Clin Pharm 1986; 21: 451-453.
3. Sacca L, Perez G, Rengo F, Pascucci I, Condorelli M. Effects of theophylline on glucose kinetics in normal and sympathectomized rats. Diabetes 1975; 24: 249-256.
4. Vestal R, Eriksson CE, Musser B, Ozali LK, Halter JB. Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular and metabolic responses in man. Circulation 1983; 67: 162.
5. Warren JB, Turner C, Dalton N, Thomson A, Cochrane GM, Clark TJH. The effect of posture on the sympathoadrenal response to theophylline infusion. Br J Clin Pharm 1983; 16: 405-411.
6. Hvidberg A, Højby Rasmussen M, Christensen NJ, Hilsted J. Theophylline enhances glucose recovery after hypoglycaemia in healthy man and in type I diabetic patients. Metabolism 1994; 43: 776-781.
7. McDermott MT, Walden TL, Bornemann M, Sjoberg RJ, Hofeldt FD, Kidd GS. The effects of theophylline and nifedipine on corticotropin-stimulated cortisol secretion. Clin Pharmacol Ther 1990; 47: 435-438.
8. Tulin-Silver J, Schteingart DE, Mathews KP. Effect of theophylline on cortisol secretion. J Allergy Clin Immunol 1981; 67: 45-50.
9. Andersson KE, Johannesson N, Karlberg BE, Persson CGA. Increase in plasma free fatty acids and natriuresis by xanthines may reflect adenosine antagonism. Eur J Clin Pharmacol 1984; 26: 33-38.
10. Kerr D, Sherwin RS, Pavalkis F, Fayad PB, Sikorski L, Rife F, et al. Effect of caffeine on the recognition of and responses to hypoglycaemia in humans. Ann Intern Med 1993; 119: 799-804.
11. Lefebvre PJ, Scheen AJ. The use of acarbose in the prevention and treatment of hypoglycemia. Eur J Clin Invest 1994; 24 (suppl 3): 40-44.
12. Wiethop BV, Cryer PE. Alanine and terbutaline in the treatment of hypoglycemia in insulin dependent diabetes mellitus. Diabetes Care 1993; 16: 1131-1135.
13. Debrah K, Sherwin RS, Murphy J, Kerr D. Effect of caffeine on recognition of and physiological responses to hypoglycemia in insulin-dependent diabetes. Lancet 1996; 347: 19-24.
14. Gimeno F, Steenhuis EJ, Jonkman JHG. Effect of theophylline on cortisol plasma concentrations in patients with chronic obstructive pulmonary disease. Int J Clin Pharmacol Ther Toxicol 1990; 28: 139-143.
15. Robertson D, Wade D, Workman R, Woosley RL, Oates JA. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 1981; 67: 1111-1117.
16. Lalonde RL, Bottorff MB, Straughn AB. Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay methods in a theophylline pharmacokinetic study. Therapeutic Drug Monitoring 1985; 7: 442-446.
17. Philipsen EK, Myhre J, Larsen S, Damkjær Nielsen M, Holst JJ, Hilsted J. The relationship between some beta-adrenergic mediated responses and plasma concentrations of adrenaline and cyclic AMP in man. Acta Endocrinol 1990; 122: 115-120.
18. Järhult J, Holst JJ. Reflex adrenergic control of endocrine pancreas evoked by unloading of carotid baroreceptors in cats. Acta Physiol Scand 1978; 104: 188-202.
19. Christensen NJ, Vestergaard P, Sørensen P, Rafaelsen OJ. Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiatrica Scandinavica 1980; 61: 178-182.
20. Albertsson-Wikland K, Jansson C, Rosberg S, Novamo A. Time-resolved immunofluorometric assay of human growth hormone. Clin Chem 1993; 39: 1-7.
21. Rizza RA, Cryer PE, Gerich JE. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J Clin Invest 1979; 64: 62-71.
22. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 1959; 82: 420-430.
23. De Bodo RC, Steel R, Altszuler N, Dunn A, Bishop JS. On the hormonal regulation of carbohydrate metabolism; studies with C14 glucose. Recent Prog Horm Res 1963; 19: 445-488.
24. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV. Identification of type 1 diabetic patients at increased risk for hypoglycaemia during intensive therapy. N Engl J Med 1983; 308: 485-491.
25. Bolli GB, De Feo P, De Cosmos S, Perriello G, Ventura M, Benedetti MM, et al. A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes 1984; 33: 732-737.